Tag Archives: Canada-US trade

Investor Arbitration and Public Regulation

On August 27, 2014, a NAFTA panel dismissed a claim by the Canadian pharmaceutical company, Apotex Inc., that had argued that the US government had breached the non-discrimination clauses in the Agreement by issuing an Import Alert over the company’s Canadian drug manufacturing processes. In 2008 -2009. the US Food and Drug Administration had inspected… Read More »